Corpus Christi Physician to Host Walk With a Doc Texas Event
June 18, 2025 ● WHAT: Corpus Christi residents of all ages are encouraged to lace up their walking shoes and join Jacqueline Reyes-Diaz, MD, of Nueces County Medical Society for the launch of their second monthly Walk with a Doc Texas event. ● WHEN: Saturday, June 21, at 9 am (recurring monthly every third Saturday […]
FDA Approves Nipocalimab for Adult and Pediatric Myasthenia Gravis
The FDA approved nipocalimab (Imaavy) injection to treat adults and children ages 12 and older with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) or anti-muscle-specific kinase (MuSK) antibody positive, Johnson & Johnson announced Wednesday. Nipocalimab is designed to block the immunoglobulin G (IgG) binding site on the neonatal Fc receptor (FcRn) to reduce […]
Novel Drug Approved for All Duchenne Muscular Dystrophy Variants
The FDA approved oral givinostat (Duvyzat) to treat Duchenne muscular dystrophy (DMD) in patients ages 6 years and older, the agency announced Thursday. Givinostat is a histone deacetylase (HDAC) inhibitor that targets pathogenic processes to reduce inflammation and loss of muscle. It’s the first nonsteroidal drug approved for patients with all genetic variants of DMD, […]
RSV Vaccine Benefits Probably Outweigh Small Neurologic Risk, CDC Advisors Say
The benefits of vaccination against respiratory syncytial virus (RSV) for adults ages 60 and older probably outweigh the small risk of vaccine-related Guillain-Barré syndrome (GBS), the CDC’s Advisory Committee on Immunization Practices (ACIP) reaffirmed. In a presentation on the second day of the ACIP’s 2-day meeting, Amadea Britton, MD, of the CDC’s RSV adult vaccination […]
Older Adults Should Get Another COVID Booster, CDC Advisors Say
Adults ages 65 and older should receive an additional dose of the 2023-2024 COVID-19 vaccine this spring, according to CDC’s Advisory Committee on Immunization Practices (ACIP). Eleven members of the committee voted in favor of the recommendation, one member voted no, and one abstained from voting. Shortly after the meeting, CDC Director Mandy Cohen, MD, […]
Less-Frequent Surveillance Mammo Feasible in Older Breast Cancer Survivors
SAN ANTONIO — Women ages >50 who de-escalated to less-frequent mammography 3 years after curative surgery for early-stage breast cancer had similar outcomes to women who received annual mammography, according to a phase III study. In the Mammo-50 trial, after a median follow-up of 5.7 years for alive patients, breast cancer-specific survival was 98.1% and […]
Ultra-Rare Immune System Disease Gets First FDA-Approved Treatment
The FDA approved pozelimab (Veopoz) as the first treatment for adults and children ages 1 year and up with CD55-deficient protein-losing enteropathy. Also known as CHAPLE (complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy) disease, CD55-deficient protein-losing enteropathy is an inherited disease marked by mutations of the complement regulator CD55 gene, which causes the complement system […]
The Biggest Early Warning Signs Of Bacterial Meningitis
Edwin Tan via Getty Images Approximately 21% of meningococcal disease cases affect young people ages 11 to 24. Bacterial meningitis, a potentially fatal infection that causes the protective membranes of the brain and spine to become inflamed, is relatively rare. According to the National Meningitis Association, about “600 – 1,000 people contract meningococcal disease in […]
More Young Kids Can Get Bivalent COVID Booster
More children under age 5 are now eligible for a COVID-19 booster, the FDA announced on Tuesday. Kids ages 6 months to 4 years who completed their primary vaccination with three doses of the monovalent Pfizer-BioNTech shot can now get a booster with the companies’ bivalent COVID vaccine — which targets the Omicron BA.4/5 subvariants […]
CDC Details Abysmal COVID Vaccination Rate in Youngest Kids
COVID-19 vaccination coverage in kids ages 6 months to 4 years was exceedingly low in the 6 months following FDA’s authorization last June, CDC data showed. Through the end of 2022, only 10.1% of children in this age group had received at least one dose of Moderna or Pfizer’s mRNA vaccine, and just 5.1% had […]